PSMAI cut-off value for mortality in men: 680.1 mm2/m2
Descrição
Increased prostate cancer specific mortality following radical prostatectomy in men presenting with voiding symptoms—A whole of population study - ScienceDirect
ESMO 2021: PRINCE: Interim Analysis of the Phase Ib Study of 177Lu-PSMA-617 in Combination With Pembrolizumab for Metastatic Castration Resistant Prostate Cancer
Prostate Cancer Mortality Among Elderly Men After Discontinuing Organised Screening: Long-term Results from the European Randomized Study of Screening for Prostate Cancer Rotterdam - ScienceDirect
Computed tomographic images at the the middle third lumbar vertebral
Correlation of SUVmax and Apparent Diffusion Coefficient Values Detected by Ga-68 PSMA PET/MRI in Primary Prostate Lesions and Their Significance in Lymph Node Metastasis: Preliminary Results of an On-going Study - Abstract
Head-to-head comparison of 68Ga-PSMA-11 PET/CT and 68Ga-PSMA-11 PET/MRI in the detection of biochemical recurrence of prostate cancer: summary of head-to-head comparison studies
ASCO GU 2022: Predicting the Outcome of mCPRC Patients after Lu-177 PSMA Therapy Using Semi-Quantitative and Visual Criteria in Baseline PSMA PET: An International Multicenter Retrospective Study
Long-term survival outcomes of salvage [225Ac]Ac-PSMA-617 targeted alpha therapy in patients with PSMA-expressing end-stage metastatic castration-resistant prostate cancer: a real-world study
3-Year Freedom from Progression After 68Ga-PSMA PET/CT–Triaged Management in Men with Biochemical Recurrence After Radical Prostatectomy: Results of a Prospective Multicenter Trial
Two chemoattenuated PfSPZ malaria vaccines induce sterile hepatic immunity
Cemalettin AYDIN, Inonu University, Malatya, Faculty of Medicine
ESMO 2021: PRINCE: Interim Analysis of the Phase Ib Study of 177Lu-PSMA-617 in Combination With Pembrolizumab for Metastatic Castration Resistant Prostate Cancer
PSMAI cut-off value for mortality in men: 680.1 mm2/m2
de
por adulto (o preço varia de acordo com o tamanho do grupo)
